{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:15:45Z","timestamp":1790572545095,"version":"4.1.0"},"reference-count":47,"publisher":"Impact Journals, LLC","issue":"69","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,12,26]]},"DOI":"10.18632\/oncotarget.22817","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T17:57:23Z","timestamp":1512151043000},"page":"113673-113686","source":"Crossref","is-referenced-by-count":27,"title":["Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma"],"prefix":"10.18632","volume":"8","author":[{"given":"Marieke","family":"Hylebos","sequence":"first","affiliation":[{"name":"Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium"},{"name":"Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Van Camp","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium"},{"name":"Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Vandeweyer","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Fransen","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium"},{"name":"StatUa Center for Statistics, University of Antwerp, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Beyens","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium"},{"name":"Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Cornelissen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Erasmus Medical Center Cancer Institute, 3015 Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvid","family":"Suls","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pauwels","sequence":"additional","affiliation":[{"name":"Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium"},{"name":"Laboratory of Pathology, Antwerp University Hospital, 2650 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"van Meerbeeck","sequence":"additional","affiliation":[{"name":"Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium"},{"name":"Thoracic Oncology, Antwerp University Hospital, 2650 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Op de Beeck","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium"},{"name":"Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"1","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","author":"Harris","year":"2004"},{"key":"2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30227","article-title":"The pathogenesis of mesothelioma","volume":"29","author":"Testa","year":"2002","journal-title":"Semin Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Lake","year":"2005","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1289\/ehp.1002285","article-title":"The case for a global ban on asbestos","volume":"118","author":"Takahashi","year":"2010","journal-title":"Environ Health Perspect"},{"key":"5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","article-title":"Malignant pleural mesothelioma: the standard of care and challenges for future management","volume":"78","author":"Baas","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"6","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Paoletti","year":"2003","journal-title":"J Clin Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<649::AID-IJC25>3.0.CO;2-2","article-title":"The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma","volume":"75","author":"Versnel","year":"1998","journal-title":"Int J Cancer"},{"key":"8","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer","volume":"55","author":"Minna","year":"1995","journal-title":"Cancer Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Powell","year":"2011","journal-title":"Nat Genet"},{"key":"10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/bjc.1989.326","article-title":"Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma","volume":"60","author":"Knuutila","year":"1989","journal-title":"Br J Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bjc.1997.91","article-title":"Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma","volume":"75","author":"Knuutila","year":"1997","journal-title":"Br J Cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/bjc.1998.42","article-title":"Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung","volume":"77","author":"Knuutila","year":"1998","journal-title":"Br J Cancer"},{"key":"13","first-page":"450","article-title":"Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma","volume":"59","author":"Testa","year":"1999","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/path.1128","article-title":"Molecular cytogenetic differences between histological subtypes of malignant mesotheliomas: DNA cytometry and comparative genomic hybridization of 90 cases","volume":"197","author":"Johnen","year":"2002","journal-title":"J Pathol"},{"key":"15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1349-7006.2006.00386.x","article-title":"Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32","volume":"98","author":"Sekido","year":"2007","journal-title":"Cancer Sci"},{"key":"16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ijc.23949","article-title":"Genomic events associated with progression of pleural malignant mesothelioma","volume":"124","author":"Pass","year":"2009","journal-title":"Int J Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/onc.2009.455","article-title":"The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival","volume":"29","author":"Testa","year":"2010","journal-title":"Oncogene"},{"key":"18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/15384047.2016.1145850","article-title":"Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration","volume":"17","author":"Testa","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Gustafson","year":"2016","journal-title":"Nat Genet"},{"key":"20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","article-title":"BEDTools: a flexible suite of utilities for comparing genomic features","volume":"26","author":"Hall","year":"2010","journal-title":"Bioinformatics"},{"key":"21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","article-title":"A census of human cancer genes","volume":"4","author":"Stratton","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","article-title":"The transcriptional coactivators p300 and CBP are histone acetyltransferases","volume":"87","author":"Nakatani","year":"1996","journal-title":"Cell"},{"key":"23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/30538","article-title":"Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation","volume":"393","author":"Yokoyama","year":"1998","journal-title":"Nature"},{"key":"24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/ng1297-498","article-title":"Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT","volume":"17","author":"Andrews","year":"1997","journal-title":"Nat Genet"},{"key":"25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/cr.2007.115","article-title":"Mechanisms and functions of DNA mismatch repair","volume":"18","author":"Li","year":"2008","journal-title":"Cell Res"},{"key":"26","first-page":"51","article-title":"The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions","volume":"99","author":"Zakowski","year":"2003","journal-title":"Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPT94JVWIHBKRD","article-title":"Diagnostic usefulness of p16\/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis","volume":"139","author":"Tagawa","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1505270","article-title":"Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer","volume":"373","author":"Cristofanilli","year":"2015","journal-title":"N Engl J Med"},{"key":"29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","article-title":"Treating cancer with selective CDK4\/6 inhibitors","volume":"13","author":"Turner","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"30","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","article-title":"p300\/CBP and cancer","volume":"23","author":"Caldas","year":"2004","journal-title":"Oncogene"},{"key":"31","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s00018-006-6274-5","article-title":"SET domain protein lysine methyltransferases: Structure, specificity and catalysis","volume":"63","author":"Zhou","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biochi.2008.10.019","article-title":"Polybromo-1: the chromatin targeting subunit of the PBAF complex","volume":"91","author":"Thompson","year":"2009","journal-title":"Biochimie"},{"key":"33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ijc.29015","article-title":"Biallelic germline and somatic mutations in malignant mesothelioma: multiple mutations in transcription regulators including mSWI\/SNF genes","volume":"136","author":"Hashimoto-Tamaoki","year":"2015","journal-title":"Int J Cancer"},{"key":"34","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.1612074113","article-title":"High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma","volume":"113","author":"Tanji","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.yexmp.2014.09.016","article-title":"Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets","volume":"97","author":"Ortiz-Quintero","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00000478-200203000-00011","article-title":"Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas","volume":"26","author":"Ferrans","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"38","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/onc.2013.351","article-title":"Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma","volume":"33","author":"Jean","year":"2014","journal-title":"Oncogene"},{"key":"39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/pros.20522","article-title":"Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer","volume":"67","author":"Scarpinato","year":"2007","journal-title":"Prostate"},{"key":"40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/carcin\/bgw116","article-title":"Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer","volume":"38","author":"Adam","year":"2017","journal-title":"Carcinogenesis"},{"key":"41","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction","volume":"66","author":"Ladanyi","year":"2006","journal-title":"Cancer Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-008-0689-3","article-title":"Prognostic significance of p16\/cdkn2a loss in pleural malignant mesotheliomas","volume":"453","author":"Gibbs","year":"2008","journal-title":"Virchows Arch"},{"key":"43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lungcan.2008.02.013","article-title":"Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma","volume":"62","author":"Date","year":"2008","journal-title":"Lung Cancer"},{"key":"44","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/bjc.2015.27","article-title":"MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14\/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53","volume":"112","author":"Wohlschlaeger","year":"2015","journal-title":"Br J Cancer"},{"key":"45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2016.07.011","article-title":"Low homozygous\/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma","volume":"99","author":"Nabeshima","year":"2016","journal-title":"Lung Cancer"},{"key":"46","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Mesirov","year":"2006","journal-title":"Nat Genet"},{"key":"47","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2015"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T09:49:45Z","timestamp":1719654585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":47,"journal-issue":{"issue":"69","published-print":{"date-parts":[[2017,12,26]]}},"alternative-id":["22817","29371938"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.22817","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}